Added to YB: 2022-08-23
Pitch date: 2022-08-23
GLPG [bullish]
Galapagos NV
-45.82%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.
Market Cap
EUR 1.8B
Pitch Price
EUR 50.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
4.56
P/E
-4.05
EV/Sales
-4.33
Sector
Biotechnology
Category
N/A
Show full summary:
GALAPAGOS NV GLPG
A summary for this pitch has not been created yet.
Read full article (0 min)